action spectra
Recently Published Documents


TOTAL DOCUMENTS

496
(FIVE YEARS 13)

H-INDEX

60
(FIVE YEARS 2)

2021 ◽  
Vol 118 (40) ◽  
pp. e2015867118
Author(s):  
Antony R. Young ◽  
Kylie A. Morgan ◽  
Graham I. Harrison ◽  
Karl P. Lawrence ◽  
Bibi Petersen ◽  
...  

Action spectra are important biological weighting functions for risk/benefit analyses of ultraviolet (UV) radiation (UVR) exposure. One important human benefit of exposure to terrestrial solar UVB radiation (∼295 to 315 nm) is the cutaneous synthesis of vitamin D3 that is initiated by the photoconversion of 7-dehydrocholesterol to previtamin D3. An action spectrum for this process that is followed by other nonphotochemical steps to achieve biologically active vitamin D3 has been established from ex vivo data and is widely used, although its validity has been questioned. We tested this action spectrum in vivo by full- or partial-body suberythemal irradiation of 75 healthy young volunteers with five different polychromatic UVR spectra on five serial occasions. Serum 25-hydroxyvitamin D3 [25(OH)D3] levels, as the most accurate measure of vitamin D3 status, were assessed before, during, and after the exposures. These were then used to generate linear dose–response curves that were different for each UVR spectrum. It was established that the previtamin D3 action spectrum was not valid when related to the serum 25(OH)D3 levels, as weighting the UVR doses with this action spectrum did not result in a common regression line unless it was adjusted by a blue shift, with 5 nm giving the best fit. Such a blue shift is in accord with the published in vitro action spectra for vitamin D3 synthesis. Thus, calculations regarding the risk (typically erythema) versus the benefit of exposure to solar UVR based on the ex vivo previtamin D3 action spectrum require revision.


Author(s):  
Mikhail Lyulyukin ◽  
Nikita Kovalevskiy ◽  
Dmitry Selishchev ◽  
Denis Kozlov

Author(s):  
Paul Donald Forbes ◽  
Curtis A. Cole ◽  
Frank deGruijl
Keyword(s):  

Cephalalgia ◽  
2020 ◽  
pp. 033310242096385
Author(s):  
Andrew J Zele ◽  
Ashim Dey ◽  
Prakash Adhikari ◽  
Beatrix Feigl

Purpose To define the melanopsin and cone luminance retinogeniculate pathway contributions to photophobia in healthy controls and migraineurs. Methods Healthy controls and migraineurs were categorized according to the International Classification of Headache Disorders criteria. Photophobia was measured under full-field illumination using electromyography in response to narrowband lights spanning the melanopsin and cone luminance action spectra. Migraineurs were tested during their interictal headache-free period. Melanopsin-mediated post-illumination pupil responses quantified intrinsically photosensitive Retinal Ganglion Cell (ipRGC) function. Results A model combining the melanopsin and cone luminance action spectra best described photophobia thresholds in controls and migraineurs; melanopsin contributions were ∼1.5× greater than cone luminance. In the illumination range causing photophobia, migraineurs had lower photophobia thresholds (∼0.55 log units; p < 0.001) and higher post-illumination pupil response amplitudes ( p = 0.03) than controls. Conclusion Photophobia is driven by melanopsin and cone luminance inputs to the cortex via the retino-thalamocortical pathway. In migraineurs, lower photophobia thresholds reflect hypersensitivity of ipRGC and cone luminance pathways, with the larger and prolonged post-illumination pupil response amplitude indicative of a supranormal melanopsin response. Our findings inform artificial lighting strategies incorporating luminaires with low melanopsin excitation and photopic luminance to limit the lighting conditions leading to photophobia.


Science ◽  
2020 ◽  
Vol 368 (6498) ◽  
pp. 1426-1427
Author(s):  
Perdita Barran

Sign in / Sign up

Export Citation Format

Share Document